3Hoffmeiser HM,Jur M.Wemdel HP,et al.Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and post acute phase in patients with unstable angina pectoris[J].Circulation,1995,91:2520-2531.
4CooK NS,Ubben D.Fibrinogen as a major risk in cardiovascular disease [J].Trends Pharmacol Sci,1990,11:444-447
5Ermst E.Fibrinogen:an important risk factor for atherothrombotic diseases[J].Ann Med,1994,26(1):15-19.
6Mis-pelaere D,Glerant JC,Audebert M,et al.Pulmonary embolism and sibilant types of chronic obstructive pulmonary disease decompensations [J].Rev-Mal-Respir,2002,19(4):415-423.
7HartmannlJ,HagenPJ,Melissant CF,etal.Effect of ChronicObstructive Pulmonary Disease on the Performance of D-dimer Testing,Ventilation/Perfusion scintigraphy,Spiral Computed Tomographic Angiography,and Conventional Angiography [ J ].Am J Respir Crit Care Med,2000,162(6):2232-2237.
8Danl M,Tybjaerg-Hansen A,Vestbo J,et al.Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2001,15,164(6):1008-1011.
9Cordova C,Violi F,Alessandri C,et al.Improvement of blood gas levels after calciumheparin treatment in patients with chronic onstructive pulmonary disease[J].Thromb Res,1992,68:435-440.
